Dr Giotikas commented:
"I am very excited with this development. All of us who are interested in cosmetic limb lengthening, patients and physicians alike, should be grateful to the first generation of specialists who envisaged and pioneered the production of such a sophisticated device.
I anticipate that Stryde will be greatly beneficial to patients by:
The initiation of a prospective study protocol at Athens BJR to look exactly at these and other aspects of cosmetic limb lengthening couldn't be better timed. We hope that we will be one of the first centers to publish sound clinical evidence on the performance of Stryde.
At the dawn of the new era, it is our duty to responsibly utilize the available technology, through appropriate patient selection, to offer the merits of cosmetic limb lengthening to those who will really benefit from it."
In the field of cosmetic limb lengthening, the introduction of the Athena Method, has increased the scientific knowledge on the human body proportions, and has benefited our patients by giving them the confidence to make informed decisions about their body.
At the dawn of 2019, we abide stronger than ever to our moto: "We Know How to Care", ready to welcome and serve an anticipated increased clinical workload. We are also starting two important clinical studies to find evidence-based answers about the functional outcome after cosmetic limb lengthening and about the shortening of time to bone consolidation.
Wishing you a joyful Festive Season, a very Merry Christmas, and a prosperous New Year."
Dr Dimitrios Giotikas MD, PhD
Consultant Surgeon in Trauma & Orthopaedics
Clinical Director Athens BJR
Dr Dimitrios Giotikas at the Annual Conference of British Limb Reconstruction Society, 15-16 March 2018, Southampton, UK
We are delighted to announce that Dr Dimitrios Giotikas has been invited to present the results of his research study: "The Human Body Proportions in the Preoperative planning of Cosmetic Limb Lengthening" at the Annual Meeting of British Limb Reconstruction Society (BLRS) on 15-16 March 2018 at Southampton, United Kingdom.
See the full submitted abstract of the study
Title: The Human Body Proportions in the Preoperative planning of Cosmetic Limb Lengthening
Author (& presenting): Mr Dimitrios Giotikas, MD, PhD
Consultant Surgeon in Trauma & Orthopaedics
John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust
Distraction histogenesis is utilised for cosmetic reasons in patients with constitutional short stature, achondroplasias, or height dysphoria. One of the considerations of patients and surgeons alike, is the preservation of aesthetically acceptable body proportions after the lengthening i.e which segment of the lower limb to lengthen and by how much, in order to preserve the patient’s proportions within -or as close as possible to- the normal range of human body proportions. Sound anthropometric data on the normal range of the human body proportions is currently lacking. The aim of this study is to calculate the normal range of the ratio between the lengths of the lower limb, upper limb, femur, tibia, stature and trunk.
Data form standardized measurements of the lengths of the tibia, femur, arm, stature, lower limb, upper limb was obtained from a sample population of 6068 healthy men and women servicing in the US Army. The mean, median, range and standard deviation were calculated for the following ratios of lengths: whole lower limb/leg, Stature/leg, Whole lower limb/thigh, Stature/thigh, Siting height/whole lower limb, Stature/Whole lower limb, Arm Span/Stature, Whole upper limb/Whole lower limb.
The ratios show normal distribution. Results are presented separately for men and women for the total sample population and for subgroups based on ethnic origin (White, Black, Hispanic and Asian).
This study is one of the first to provide specific anthropometric data from a large sample population relevant to the evidence-based preoperative planning and patient counselling before cosmetic limb lengthening procedures.
Learn more about the 2018 Annual International BLRS Conference
We are excited to welcome Robert Rozbruch from HSS amongst other international and national speakers.
The AHP programme will include theatre/ nurse and physiotherapy professionals. As a first there will be a dedicated session run by scrub staff on pre-building ring blocks/ frames significantly shortening operative time.
The conference dinner will be a special event showcasing the taste of the Punjab. A Street food reception will precede the main sit down event with courses highlighting food from Amritsar to Lahore. It promises to be a fantastic evening with guest speakers and entertainment. Partners are very welcome.
The meeting will be at The Hilton Ageas Bowl, a newly built facility with views of the cricket pitch from the bar/ restaurant and selected rooms and a fantastic Spa facility. Discounted packages for the Spa for attending partners have been arranged
We look forward to seeing you in Southampton.
Dr Dimitrios Giotikas said:
"I am looking forward to sharing this newly acquired knowledge with my esteemed colleague surgeons from all over the world.
Preservation of body proportions after cosmetic limb lengthening has always been a huge concern for cosmetic height lengthening candidates.
We now have robust data- based on the largest sample population- to accurately plan our surgery and to answer to our patients' fundamental question; which part of their limb to lengthen and by how much in order to remain within the range of the natural human body proportions...How exciting is that!"
...This is the title of the study that Athens BJR is conducting with the support of U.S. Army Research & Engineering Center, with the aim to end all concerns about body proportions after cosmetic limb lengthening.
The study will calculate the normal range of ratios between the lengths of upper limbs, lower limbs, thighs, shins, span and stature in a sample population of more 5900 healthy men and women , in order to answer the following question:
“For a given person, which part of the limb (femur or tibia) should be lengthened and by how much, in order to keep the body proportions of the patient after the lengthening as close as possible to the normal range of human body proportions?”
The first outcomes will be available in two months. Data will be presented in international scientific fora and will be published in scientific journals.
"Primum non nocere; first do no harm" is the fundamental ethical pilon of the medical profession derived from the Hippocratic oath itself. At the 2nd combined ASAMI-BR and ILLRS meeting in Brisbane in 2016, the issue of ethics and regulation of cosmetic limb lengthening was debated and although no formal consensus was reached, there was broad agreement on the guidelines that need to be set for cosmetic limb lengthening.
Athens BJR endorses this effort and implicitly adheres to the following proposed guidelines for ethical cosmetic limb lengthening:
Reference: Patel M. Cosmetic limb lengthening surgery: The elephant in the Room. Harm minimization not prohibition. J Limb Lengthen Reconstr [serial online] 2017 [cited 2017 Nov 12];3:73-4. Available from: http://www.jlimblengthrecon.org/text.asp?2017/3/2/73/213565
Medical travel is projected to expand globally in the next decade. Citizens in the United States of America, for instance, already receive significant volumes of services abroad. The growth in medical travel is largely due to improved availability of health technology, decreasing costs for travel and advertising by companies wishing to attract patients. Medical tourism has been described as “travel across international borders with the intention of receiving some form of medical treatment.
There are considerable gaps in the current literature concerning the extent to which international health services are consumed and the needs of medical travellers are met. We suggest three key domains (quality standards, informed decision-making, economic and legal protection) for which scientific evidence would support the development of medical travel policies.
To establish international quality standards, definitions and comparable indicators should be established, with oversight from a major international body.
More data on patient decision-making needs to be collected to ensure the practical value of any evidence generated on medical travel. The drivers and barriers that precede medical travel need to be assessed beyond general economic and availability factors.
To prevent harm, legal and economic frameworks for medical travel are needed. Existing governance structures and legal frameworks on treatment and care standards need to be harmonized and international quality standards need to be enforced and maintained.
Effective research in medical travel as a global phenomenon requires consideration of all three domains, with the overall goal of improving access, quality of care, and health equity.
Source: Bulletin of the World Health Organization